Publication | Closed Access

Different metabolic correlations of thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 in non-obese type 2 diabetic patients

ObesityThrombosisMetabolic SyndromeHealth SciencesCardiovascular DiseaseMedicinePhysiologyDiabetesFibrinolysisDifferent Metabolic CorrelationsDiabetes MellitusPharmacologyNon-obese Type 2AtherosclerosisThrombin-activatable Fibrinolysis Inhibitor